Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency
Clinical trial NCT02112994 · COMPLETED
Trial details
- NCT number
- NCT02112994
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-24
- Primary completion
- 2017-12-28
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.